Search
Search Results
##search.searchResults.foundPlural##
-
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1096PDF: 519HTML: 161 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1201PDF: 496HTML: 282 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4644PDF: 1802HTML: 1279 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3489PDF: 1547HTML: 4083 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1741PDF: 1064HTML: 553 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2817PDF: 1016HTML: 3743 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1680PDF: 1026HTML: 232 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1330PDF: 554HTML: 23213 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2132PDF: 155HTML: 41 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1316PDF: 690HTML: 7769 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4519PDF: 1810HTML: 1126 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
589PDF: 289HTML: 144 -
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3032PDF: 1156HTML: 132 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2401PDF: 865HTML: 476 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3073PDF: 1076HTML: 1685 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1121PDF: 758HTML: 280 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5862PDF: 1589HTML: 1666Untitled: 270 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3746PDF: 2616HTML: 1649 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3331PDF: 1409HTML: 4158 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1715PDF: 867HTML: 1279Figure 1: 207Figure 2: 217Figure 3: 220 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1108PDF: 1069Suppl. Files: 670HTML: 195 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3887PDF: 1664HTML: 870Figures . Eliassian: 268 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3464PDF: 1309HTML: 8397 -
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4179PDF: 1218HTML: 2113Fig.1: 237Fig. 2: 130Table 1: 238Table2: 256Table 3: 234 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2711PDF: 1691HTML: 2453Table1: 219 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3540PDF: 1347HTML: 2369Fi.1 Gritti.Rambaldi: 250







